The influence of the p53 gene on the in vitro chemosensitivity of colorectal cancer cells

Journal of Cancer Research and Clinical Oncology

Volumn 125, Issue 6, 1999, Pages 357-360

  Zheng, Minhua ^a   Wang, Hao ^a   Zhang, Haobo ^a   Ou, Qishui ^b   Shen, Baihua ^b   Li, Ningli ^b   Yu, Baoming ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b Shanghai Institute of Immunology   (China)

Author keywords

Apoptosis; Chemosensitivity; Colorectal neoplasms; P53 gene

Indexed keywords

10 HYDROXYCAMPTOTHECIN; DNA NUCLEOTIDYLEXOTRANSFERASE; FLUOROURACIL; FOLINIC ACID; PROTEIN P53;

ADULT; AGED; APOPTOSIS; ARTICLE; CHEMOSENSITIVITY; CLINICAL ARTICLE; COLORECTAL CANCER; CORRELATION FUNCTION; DRUG RESPONSE; ENZYME ASSAY; FEMALE; GENE MUTATION; HUMAN; IN VITRO STUDY; MALE; ONCOGENE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; APOPTOSIS; CAMPTOTHECIN; COLORECTAL NEOPLASMS; DRUG RESISTANCE, NEOPLASM; FEMALE; FLUOROURACIL; GENES, P53; HUMANS; MALE; MIDDLE AGED; MUTATION; RETROSPECTIVE STUDIES;

EID: 0033024526     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320050286     Document Type: Article

References (27)

1. Armand JP, Ducreux M, Mahjoubi M et al (1995) CPT-11 in the treatmnet of colorectal cancer. Eur J Cancer 31 A (7-8):1283-7
2. Bautista D, Chaubert P, Bertoncini J et al (1994) Detection of p53 gene mutation in cancer tissue by non radioactive direct sequencing PCR. Methods Applications 4:76-9
3. Chang WF, Chen CF, Wu UL et al (1991) Cytotoxic activities of tanshinone against human carcinoma cell lines. Am J Chin Med 19:207-9
4. Clarke AR, Purdie CA, Harrison DJ et al (1993) Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362:849-52
5. Conti JA, Kemeny NE, Saltz LB et al (1996) Irinotecan is an active agent in untreated patients with metastatic colorectal cancer J Clin Oncol 14:709-15
6. Dive C, Hickman JA (1991) Drug-target interaction:only the first step in the commitment to a programmed cell death? Br J Cancer 64:192-6
7. Eldiry WS, Tokino T, Veloulecu VE et al (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-25
8. Francini G, Petrioli R, Lorenzini F et al (1994) Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer. Gastroenterology 106:42-8
9. Pritsche M, Haessler C, Brandner G (1993) Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA damaging agents. Oncogene 8:307-18
10. Goh HS, Yao J, Smith DR et al (1995) P53 point mutation and survival in colorectal cancer patients. Cancer Res 55:5217-21
11. Gorczyca W, Gong J, Darzynkiewicz Z (1993) Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynudeotidyl transferase and nick translation assay. Cancer Res 53:1945-51
12. Hamelin R, Laurent PP, Olschwang S et al (1994) Association of p53 mutations with short survival in colorectal cancer. Gastroenterology 106:42-8
13. Hansen RM (1990) Systemic therapy in metastatic colorectal cancer. Arch Intern Med 150:2205-9
14. Harris CC, Hollstei M (1993) Clinical implications of the p53 tumor suppressor gene. N Engl J Med 329:1318-27
15. Hickman JA (1992) Apoptosis induced by anticancer drugs. Cancer Metasis Rev 11:121-39
16. Lane DP (1992) P53 guardian of the genome. Nature 358:15-6
17. Lowa SW, Ruleg HE, Jackes T et al (1993) P53 dependent apo-tosis modulates the cytotoxicity of anticancer agents. Cell 74:957-67
18. Lowa SW, Bodis S, McClatchey A et al (1994) P53 status and the efficacy of cancer therapy in vivo. Science 266:807-10
19. Kastan MB, Onyerwere O, Sidransky D et al (1991) Participation of p53 protein in the cellular response to DNA damager. Cancer Res 51:6304-11
20. Krajewska M, Moss SF, Krajewski S et al (1996) Elevated expression of bcl-x and reduced bak in primary colorectal adenocarcinomas. Cancer Res 56:2422-7
21. Reed JC (1994) Bcl-2 and the regulation of programmed cell death. J Cell Biol 124:1-6
22. Ruoslahti E, Reed JC (1994) Anchorage dependence, integrins, and apoptosis. Cell 77:477-8
23. Shimada Y, Yoshino M, Wakui A et al (1993) Phase II study of CPT-11, a new camptothecin derivative in metastatic colorectal cancer. J Clin Oncol 11:909-13
24. Shimada Y, Rougier P, Pitot H (1996) Efficacy of CPT-11 as a sungle agent in metastatic colorectal cancer. Eur J Cancer 32 A Suppl3:S13-7
25. Williams GT (1991) Programmed cell death: apoptosis and oncogenesis. Cell 65:1097-8
26. Wyllie AH (1993) Apoptosis. Br J Cancer 67:205-8
27. Zeng ZS, Sarkis AS, Zhang ZF et al (1994) P53 nuclear overexpression: an independent predictor of survival in lymph node positive colorectal cancer patients. J Clin Oncol 12: 2043-50